Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
申请人:Kindrachuk David E.
公开号:US20090156613A1
公开(公告)日:2009-06-18
Bicyclic heteroaryl-substituted imidazole compounds are described, which are useful as H
4
receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H
4
receptor activity and for the treatment of disease states, disorders, and conditions mediated by H
4
receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
描述了具有双环杂环芳基取代的咪唑化合物,这些化合物可用作H4受体调节剂。这种化合物可以用于制备药物组合物,用于调节组脊髓H4受体活性以及治疗由H4受体活性介导的疾病状态、紊乱和症状,例如过敏、哮喘、自身免疫疾病和瘙痒症。